551 related articles for article (PubMed ID: 28753840)
1. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
[TBL] [Abstract][Full Text] [Related]
2. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
[TBL] [Abstract][Full Text] [Related]
3. Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma.
Foerster B; Moschini M; Abufaraj M; Soria F; Gust KM; Rouprêt M; Karakiewicz PI; Briganti A; Rink M; Kluth L; Mathieu R; Margulis V; Lotan Y; Aziz A; John H; Shariat SF;
Clin Genitourin Cancer; 2017 Dec; 15(6):e1039-e1045. PubMed ID: 28694147
[TBL] [Abstract][Full Text] [Related]
4. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
6. Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.
Freifeld Y; Ghandour R; Singla N; Woldu S; Clinton T; Kulangara R; Bagrodia A; Matin SF; Petros FG; Raman JD; Robyak H; Yan J; Zhu H; Rapoport L; Lotan Y; Margulis V
Urol Oncol; 2019 Oct; 37(10):758-764. PubMed ID: 31378586
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
Jiang Y; Yao Z; Zhu X; Wu B; Bai S
Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
[TBL] [Abstract][Full Text] [Related]
8. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.
Fairey AS; Kassouf W; Estey E; Tanguay S; Rendon R; Bell D; Izawa J; Chin J; Kapoor A; Matsumoto E; Black P; So A; Lattouf JB; Saad F; Drachenberg D; Cagiannos I; Lacombe L; Fradet Y; Jacobsen NE
BJU Int; 2013 Oct; 112(6):791-7. PubMed ID: 23148712
[TBL] [Abstract][Full Text] [Related]
9. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial Carcinoma.
Emamekhoo H; Dhillon P; Gopalakrishnan D; Elson P; Stephenson A; Magi-Galluzzi C; McKenney J; Harper H; Haber GP; Kaouk J; Lee B; Fergany A; Berglund R; Gong M; Stein R; Krishnamurthi V; Gilligan T; Ornstein M; Rini B; Garcia J; Grivas P
Clin Genitourin Cancer; 2018 Aug; 16(4):e751-e760. PubMed ID: 29551583
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.
Winer AG; Vertosick EA; Ghanaat M; Corradi RB; Carlsson S; Sjoberg DD; Sankin AI; Sfakianos JP; Cha EK; Dalbagni G; Coleman JA
Urol Oncol; 2017 Apr; 35(4):151.e9-151.e15. PubMed ID: 27932270
[TBL] [Abstract][Full Text] [Related]
12. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
13. A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.
Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mikami S; Mizuno R; Oya M
Eur Urol Oncol; 2020 Dec; 3(6):756-763. PubMed ID: 31395480
[TBL] [Abstract][Full Text] [Related]
14. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
[TBL] [Abstract][Full Text] [Related]
15. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
[TBL] [Abstract][Full Text] [Related]
16. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma.
Xu H; Ai JZ; Tan P; Lin TH; Jin X; Gong LN; Lei HR; Yang L; Wei Q
Asian J Androl; 2020; 22(2):177-183. PubMed ID: 31169138
[TBL] [Abstract][Full Text] [Related]
18. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
